Cancer is an uncontrolled growth of cell. Uncontrolled growth of cell leads to formation of tumor which can interfere with the digestive, nervous, and circulatory systems. Tumor cell releases hormones that alter body functions. Tumors that stay in one location and show limited growth are considered as benign cancer. Whereas, the cancerous cell which flow throughout the body part, using lymph, blood, and destroying the healthy tissue are called malignant cancer. According to the American Cancer Society, cancer is the second most common cause of death in the U.S. and accounts for nearly 1 of every 4 deaths. The World Health Organization estimates that, worldwide, there were 14 million new cancer cases and 8.2 million cancer-related deaths in 2012.

There are over 200 different types of cancer, and each of which is classified by the type of cell that is initially affected. Various types of cancer include, prostrate cancer, blood cancer, lungs cancer etc. Cancer is diagnosed with the help of various in-vitro cancer test which include immunoassay, immunohistochemistry, clinical chemistry and nucleic acid tests (NAT). The global in vitro diagnostics (IVD) market size was estimated at USD 51,674.4 million in 2013.

Get free sample report : https://www.zionmarketresearch.com/sample/in-vitro-cancer-diagnostics-market

Major factors responsible for the growth of in-vitro cancer diagnostics market are the rising incidences of chronic lifestyle diseases across the globe. Furthermore, growing aging population, and increasing usage of point-of-care testing and personalized medicine are also fueling the growth of in-vitro diagnostics market. Moreover, a new range of condition-specific markers and tests with advances in genomics and proteomics and increasing investment in emerging countries are creating new opportunities for this market. However, inadequate returning policy and stringent regulatory approval framework are restraining the growth of this market. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies is expected to open growth avenues for the market over the years.

The report provides detailed segmentation of the in-vitro cancer diagnostics market based on products, technology, application and regional segment. The technology market segment held the largest market share in 2015.

Read More : https://www.zionmarketresearch.com/report/in-vitro-cancer-diagnostics-market

According to the report, the chief market players for in-vitro cancer diagnostic market are Roche Diagnostics, Abbott Laboratories, Inc., Becton, Dickson and Company, Ortho-Clinical Diagnostics, Johnson and Johnson, Danaher Corporation, Thermo Fisher Scientific, Inc, Siemens Healthcare, Bio-Rad Laboratories, Inc., Sysmex Corporation, and bioMérieux.

This report segments in-vitro cancer diagnostics market as follows:

In-vitro Cancer Diagnostic Market: Product Segment Analysis

Instruments
Reagents and Kits
Data Management System/Software
Services

In-vitro Cancer Diagnostic Market: Technology Segment Analysis

Clinical Chemistry
Immunochemistry/Immunoassays
Hematology
Coagulation and Hemostasis
Microbiology
Molecular Diagnostics
Other IVD Technologies

In-vitro Cancer Diagnostic Market: Application Segment Analysis

Laboratories
Hospitals
Academic Institutes
Point-of-care Testing
Patient Self-testing
Other End Users

In-vitro Cancer Diagnostic Market: Regional Segment Analysis

North AmericaU.S.
EuropeUK
France
Germany
Asia PacificChina
Japan
India
Latin AmericaBrazil
Middle East & Africa

Contact US:

Zion Market Research

4283, Express Lane,

Suite 634-143,

Sarasota, Florida 34249, United States

Tel: +49-322 210 92714

USA/Canada Toll Free No.1-855-465-4651

Email: [email protected]

Website: http://www.zionmarketresearch.com